Enrique Conterno

2021

In 2021, Enrique Conterno earned a total compensation of $10.4M as Chief Executive Officer at FibroGen, a 15% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$422,297
Option Awards$4,732,876
Salary$825,000
Stock Awards$4,346,820
Other$58,110
Total$10,385,103

Conterno received $4.7M in option awards, accounting for 46% of the total pay in 2021.

Conterno also received $422.3K in non-equity incentive plan, $825K in salary, $4.3M in stock awards and $58.1K in other compensation.

Rankings

In 2021, Enrique Conterno's compensation ranked 983rd out of 12,415 executives tracked by ExecPay. In other words, Conterno earned more than 92.1% of executives.

ClassificationRankingPercentile
All
983
out of 12,415
92nd
Division
Manufacturing
331
out of 5,505
94th
Major group
Chemicals And Allied Products
111
out of 2,375
95th
Industry group
Drugs
94
out of 2,096
96th
Industry
Pharmaceutical Preparations
62
out of 1,546
96th

Pay ratio

Enrique Conterno's Pay$10,385,103
Median Employee's Pay$174,414
Pay Ratio

60

to 1

In 2021, the annual total compensation of Enrique Conterno was $10,385,103.

The annual total compensation of the median employee at FibroGen was $174,414.

The ratio of Enrique Conterno's pay to the pay of median employee was therefore 60 to one.

Source: SEC filing on April 28, 2022.

Conterno's colleagues

We found six more compensation records of executives who worked with Enrique Conterno at FibroGen in 2021.

2021

Christine Chung

FibroGen

Senior Vice President, China Operations

2021

Mark Eisner

FibroGen

Chief Medical Officer

2021

Pat Cotroneo

FibroGen

Chief Financial Officer

2021

Elias Kouchakji

FibroGen

Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance

2021

Thane Wettig

FibroGen

Chief Commercial Officer

2021

Juan Graham

FibroGen

Chief Financial Officer

News

You may also like